Physician profile
Smith S Ho
NPI 1265611230
$2,039.85
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,474 · 2020: $440 · 2021: $125.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $363.08 | 2019-2020 | |
| Gilead Sciences, INC. | $250.00 | 2019 | |
| Pfizer INC. | $179.39 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $160.30 | 2019 | |
| Novartis Pharmaceuticals Corporation | $148.91 | 2019-2020 | |
| Glaxosmithkline, LLC. | $125.00 | 2019 | |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| Arbor Pharmaceuticals, INC. | $110.97 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $90.82 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.10 | 2019-2020 | |
| Corcept Therapeutics | $80.13 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $56.72 | 2019-2020 | |
| Amarin Pharma, INC. | $46.43 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $31.48 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.73 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $27.10 | 2019-2020 | |
| Lilly USA, LLC | $20.15 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.41 | 2020 | |
| Antares Pharma, INC. | $18.49 | 2019 | |
| Scilex Pharmaceuticals INC. | $17.16 | 2020 | |
| Allergan, INC. | $16.31 | 2019 | |
| Phadia US INC. | $13.75 | 2019 | |
| Grifols USA, LLC | $12.50 | 2019 | |
| Sanofi Pasteur INC. | $11.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smith Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.